Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

1.6K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
1.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.7K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.7K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union.

Bioengineering (Basel, Switzerland)·2024
Same author

When Will Real-World Data Fulfill Its Promise to Provide Timely Insights in Oncology?

JCO clinical cancer informatics·2024
Same author

The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data.

Therapeutic innovation & regulatory science·2024
Same author

HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2022
Same author

HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.

Pharmacoepidemiology and drug safety·2022
Same author

Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and <i>MET</i> Exon 14 Skipping Mutations: A Descriptive Analysis From the US.

Frontiers in oncology·2022

Related Experiment Video

Updated: May 2, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Big data, advanced analytics and the future of comparative effectiveness research.

Marc L Berger1, Vitalii Doban

  • 1Real-World Data and Analytics, Pfizer, Inc., 235 East 42nd Street, New York, NY 10017, USA.

Journal of Comparative Effectiveness Research
|March 21, 2014
PubMed
Summary

The healthcare industry is entering the big data era, driven by electronic health records and advanced analytics. This transition requires investment in technology and skills to revolutionize research and development.

More Related Videos

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

5.7K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K

Related Experiment Videos

Last Updated: May 2, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

5.7K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K

Area of Science:

  • Health Informatics
  • Data Science
  • Pharmaceutical Sciences

Background:

  • The internet boom spurred big data innovations, characterized by advanced analytics like data mining and machine learning.
  • Healthcare is poised for a similar big data transformation, influenced by regulatory shifts and increased adoption of electronic health records.
  • Integration of diverse data sources, including medical claims and electronic health records, is a key catalyst.

Purpose of the Study:

  • To explore the implications of the burgeoning big data era for the healthcare and life sciences industries.
  • To highlight the necessary investments and skill shifts required for organizations to leverage big data effectively.
  • To examine the potential impact of big data on the pharmaceutical value chain and comparative effectiveness research.

Main Methods:

  • Analysis of trends in data processing and advanced analytics adoption.
  • Review of the impact of regulatory and competitive environments on data integration.
  • Examination of investment requirements in hardware, software, and personnel.

Main Results:

  • Healthcare organizations must invest in new technologies and skilled personnel to harness big data.
  • Life science companies will see significant impacts across the entire pharmaceutical value chain.
  • Comparative effectiveness research is set to be revolutionized by big data applications.

Conclusions:

  • The healthcare sector's adoption of big data, including electronic health records and advanced analytics, necessitates strategic investments.
  • Successful transition to a big data environment will enhance pharmaceutical research, development, and comparative effectiveness studies.
  • Adapting to big data is crucial for healthcare and life science organizations to remain competitive and drive innovation.